Aegis Lifesciences
Changodar, Ahmedabad, Gujarat
GST No. 24AARCA8892L1ZS
Call 08048980621 47% Response Rate
Our Infrastructure
Aegis Lifesciences plant at Changodar, Ahmedabad, has state-of-the-art manufacturing facility fully equipped with best-in-class machinery to manufacture quality products at a very competitive price.
We have reached a reputed position in this pharmaceutical industry owing to our state-of-art infrastructural base and its modernistic facilities. Our base is further properly segmented into well-formed sub-units such as administration, accounts, R&D, production, quality control, logistic & warehousing, packaging, etc. All these units are furnished with the most modern machines and devices which enable us to manufacture products which match with the industry quality standards. Further, our units function in coordination to fulfill the huge market demands within time. In order to maximize our production rate and enhance our quality, we upgrade our facilities from time to time.
We have reached a reputed position in this pharmaceutical industry owing to our state-of-art infrastructural base and its modernistic facilities. Our base is further properly segmented into well-formed sub-units such as administration, accounts, R&D, production, quality control, logistic & warehousing, packaging, etc. All these units are furnished with the most modern machines and devices which enable us to manufacture products which match with the industry quality standards. Further, our units function in coordination to fulfill the huge market demands within time. In order to maximize our production rate and enhance our quality, we upgrade our facilities from time to time.
Research & Development Facilities
Aegis Lifesciences has full-fledged state of art R&D infrastructure, Equipment and Manpower including collaboration activities with reputes Scientific and health care institutions in India and abroad.
The R&D is well equipped to meet the requirements from Design, IPR, In-vitro testing, Design transfer meeting the highest standard of Regulatory requirements (ISO 13485: 2016 / Clause 7.2) / MRD, USFDA 510K and 21 CFR).
Aegis has been approved the DSIR accreditation (F.No. TU/ IV – RD/4698/2021) for its R&D Facility for the activities that had been undertaken in the past and for projects in future.
Some of the Key features and policies of R&D:
- Focus on developing Medical Devices and technologies in general and Devices for Bleeding management in particular, that will substantially improve techno-economic viability in health care sector
- Healthcare delivered and generate unprecedented new value for patients, providers, and payers alike including lowering healthcare costs, faster speed to value, enhancing quality of care, personalizing care for patients, products on unmet clinical conditions and making it easy for healthcare consumers to use
- Encourage and support development on national health policies, strategies and plans to have better health outcomes
- To be bench marked as the best technology driven company in the Medical Device frontier globally in development of devises for bleeding management.